As of May 24, there were 100 days until Uncleared Margin Rules (UMR) phase 6 commences, impacting a wider pool of investment managers. This phase is arguably more meaningful than the prior phases due to the threshold of uncleared over-the-counter (OTC) assets dropping to $8 billion from the prior threshold of $50 billion. This means significantly more investment firms, including banks, hedge funds and asset managers, will be subjected to these rules with an estimated 775 clients abiding by the rules vs. 319 prior to the effective date.
With the various market challenges, we have seen over the last two years through the pandemic, inflation concerns, predicted rate normalization and the Ukraine-Russia conflict, it is easy to see why attention may have been diverted from managing UMR impact and the capital efficiency challenges this may present. However, the clock is ticking and clients will likely concentrate more on this topic as the September deadline draws ever closer.
What is UMR and how does it impact market participants?
UMR are a set of rules that apply to margin (collateral) on uncleared OTC derivatives and were introduced by regulators in the wake of the 2008 financial crisis. Following the crisis, regulators wished to increase transparency, reduce systemic risk and increase the resilience of markets, especially in times of stress. OTC derivatives which were bi-lateral, opaque and often involved leverage, were focused upon as one area for improved oversight.
Uncleared margin rules have been phased in over time, initially affecting only those clients with the largest OTC exposures. However, the threshold notional of OTC exposure used to determine whether a client is affected by UMR has been consistently lowered in phases. In September 2022, phase 6 of UMR will commence, which means clients with a calculated uncleared OTC exposure over $8 billion notional will be subject to the rules.
The amount of margin that needs to be posted is often calculated according to ISDA’s Standard Initial Margin Model known as SIMM and the SIMM levels are adjusted over time.
What is the UMR impact on capital efficiency?
Capital efficiency is one factor when assessing which instrument is optimal to deploy for a given investment strategy. Other factors such as liquidity, bid-ask spread and commissions all come into the total cost equation. However, UMR’s impact is mainly on capital efficiency, and there are a variety of reasons why this is important. These include:
- To avoid performance drag caused by not being fully invested in the market
- To increase market exposure and free up capital
- To optimize capital deployment
The above reasons are expanded on in a recently published paper on capital efficiency and listed equity derivatives. The paper also highlights how we have seen capital efficient futures being increasingly adopted by clients in the equity index derivative space with Dividend Futures, Adjusted Interest Rate (AIR) Total Return Futures and Sector Futures all growing substantially in terms of volume and open interest over the last 12-24 months. As of May 10, AIR futures were trading roughly 5,000 contracts per day in 2022 (up over 250% vs 2021 average daily volume). Dividend futures were trading at 4,348 contracts per day in 2022 YTD (up 49% vs. 2021).
Other asset classes such as FX are also seeing clients increasingly look to the capital efficiency on offer via listed solutions. One area is in FX options where a recent paper identified up to 86% more capital efficiency for a given exposure via listed option instruments vs. OTC bilateral positions. The paper helps expand on the this and looks at the increasing use of listed FX options and emerging market (NDF) FX futures by real money clients.
As of May 10, CME Group saw a record in holders of large open positions in FX futures of 1,312, which followed the all-time level of open interest in FX futures and options of over 3 million contracts (~$290bn notional) earlier in the month. Asset manager adoption led the growth surge, with their positions growing by 60% since the end of Q2 2020. Buyside accounts held the most open interest positions in cleared, listed EUR/USD FX futures (60%), with hedge funds and dealers also holding significant positions at 15.4% and 24.1% respectively.
These growth trends in listed derivatives across asset classes may well continue with the clock ticking to the UMR phase deadline in September. With hundreds more firms required to meet UMR requirements, this marks an additional market development worth watching in 2022, even as all asset classes are affected by macro events.
OpenMarkets is an online magazine and blog focused on global markets and economic trends. It combines feature articles, news briefs and videos with contributions from leaders in business, finance and economics in an interactive forum designed to foster conversation around the issues and ideas shaping our industry.
All examples are hypothetical interpretations of situations and are used for explanation purposes only. The views expressed in OpenMarkets articles reflect solely those of their respective authors and not necessarily those of CME Group or its affiliated institutions. OpenMarkets and the information herein should not be considered investment advice or the results of actual market experience. Neither futures trading nor swaps trading are suitable for all investors, and each involves the risk of loss. Swaps trading should only be undertaken by investors who are Eligible Contract Participants (ECPs) within the meaning of Section 1a(18) of the Commodity Exchange Act. Futures and swaps each are leveraged investments and, because only a percentage of a contract’s value is required to trade, it is possible to lose more than the amount of money deposited for either a futures or swaps position. Therefore, traders should only use funds that they can afford to lose without affecting their lifestyles and only a portion of those funds should be devoted to any one trade because traders cannot expect to profit on every trade. BrokerTec Americas LLC (“BAL”) is a registered broker-dealer with the U.S. Securities and Exchange Commission, is a member of the Financial Industry Regulatory Authority, Inc. (www.FINRA.org), and is a member of the Securities Investor Protection Corporation (www.SIPC.org). BAL does not provide services to private or retail customers.. In the United Kingdom, BrokerTec Europe Limited is authorised and regulated by the Financial Conduct Authority. CME Amsterdam B.V. is regulated in the Netherlands by the Dutch Authority for the Financial Markets (AFM) (www.AFM.nl). CME Investment Firm B.V. is also incorporated in the Netherlands and regulated by the Dutch Authority for the Financial Markets (AFM), as well as the Central Bank of the Netherlands (DNB).